Cargando…

Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the primary causes of chronic liver disease and is closely linked to insulin resistance, type 2 diabetes mellitus (T2DM), and dyslipidemia. However, no effective drug therapies have been approved to treat this disease. The present resea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Wenlan, Zhang, Chen, Gu, Xuefang, Li, Xiaohong, Zhu, Huiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218939/ https://www.ncbi.nlm.nih.gov/pubmed/34168429 http://dx.doi.org/10.2147/DDDT.S307257

Ejemplares similares

Anti-Inflammatory Effect of the Blueberry Anthocyanins Malvidin-3-Glucoside and Malvidin-3-Galactoside in Endothelial Cells
por: Huang, Wu-Yang, et al.
Publicado: (2014)

Antiadhesive and Antibiofilm Effect of Malvidin-3-Glucoside and Malvidin-3-Glucoside/Neochlorogenic Acid Mixtures upon Staphylococcus
por: Silva, Sara, et al.
Publicado: (2022)

Malvidin Protects against and Repairs Peptic Ulcers in Mice by Alleviating Oxidative Stress and Inflammation
por: Fagundes, Felipe Leonardo, et al.
Publicado: (2021)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

Effect of Blueberry Anthocyanins Malvidin and Glycosides on the Antioxidant Properties in Endothelial Cells
por: Huang, Wuyang, et al.
Publicado: (2016)

Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
por: Li, Ting, et al.
Publicado: (2019)

Antiamnesic Potential of Malvidin on Aluminum Chloride Activated by the Free Radical Scavenging Property
por: Gilani, Sadaf Jamal, et al.
Publicado: (2022)

Malvidin’s Effects on Rat Pial Microvascular Permeability Changes Due to Hypoperfusion and Reperfusion Injury
por: Lapi, Dominga, et al.
Publicado: (2016)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Malvidin Protects WI-38 Human Fibroblast Cells Against Stress-induced Premature Senescence
por: Seo, Hye Rin, et al.
Publicado: (2016)

Cardioprotective Effects of Malvidin Against Isoproterenol-Induced Myocardial Infarction in Rats: A Mechanistic Study
por: Wei, Hui, et al.
Publicado: (2017)

Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico Approach
por: Zarricueta, Melina Luzzi, et al.
Publicado: (2022)

Acacetin Protects against Non-Alcoholic Fatty Liver Disease by Regulating Lipid Accumulation and Inflammation in Mice
por: Liou, Chian-Jiun, et al.
Publicado: (2022)

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
por: Zhang, Yali, et al.
Publicado: (2017)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Li, Nong, et al.
Publicado: (2022)

Kombiglyze (metformin and saxagliptin)‐induced hepatotoxicity in a patient with non‐alcoholic fatty liver disease
por: Thalha, Abdul Malik, et al.
Publicado: (2018)

Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway
por: Ma, Yanhong, et al.
Publicado: (2020)

Protective Effect and Mechanism of Soybean Insoluble Dietary Fiber on the Color Stability of Malvidin-3-O-glucoside
por: He, Yang, et al.
Publicado: (2022)

Food Anthocyanins: Malvidin and Its Glycosides as Promising Antioxidant and Anti-Inflammatory Agents with Potential Health Benefits
por: Merecz-Sadowska, Anna, et al.
Publicado: (2023)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
por: Zhao, Panpan, et al.
Publicado: (2023)

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
por: Sui, Yi, et al.
Publicado: (2019)

Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
por: Sheng, Guotai, et al.
Publicado: (2021)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
por: Afonso, Marta B, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol
por: Bognar, Eszter, et al.
Publicado: (2013)

Stability and Antiproliferative Activity of Malvidin-Based Non-Oxonium Derivative (Oxovitisin A) Compared with Precursor Anthocyanins and Pyranoanthocyanins
por: Wu, Muci, et al.
Publicado: (2022)

Malvidin-3-O-Glucoside Ameliorates Cadmium-Mediated Cell Dysfunction in the Estradiol Generation of Human Granulosa Cells
por: Liang, Shuer, et al.
Publicado: (2023)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lds8v5kb5dkhov3ln1iolp7mqa